15.6% Below Target

Novartis AG (NVS) has a consensus 12-month price target of $170, implying 15.6% upside from $147.08. The 25 analysts covering NVS see moderate appreciation potential.

NVS has a consensus rating of "Hold" based on 25 Wall Street analysts. The rating breakdown is mixed, with 17 Hold ratings making up the largest segment. The consensus 12-month price target of $170 implies 15.6% upside from current levels.

With a forward P/E of 16.8875x, NVS trades at a relatively low valuation. The consensus target of $170 implies 15.6% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $170 for NVS, while the most conservative target is $170. The consensus of $170 represents the median expectation. Our quantitative valuation model projects a bull case target of $227 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

NVS is heavily covered by Wall Street, with 25 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 17 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month NVS stock forecast based on 25 Wall Street analysts shows a consensus price target of $170, with estimates ranging from $170 (bear case) to $170 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $173, with bear/bull scenarios of $109/$227.

Our quantitative valuation model calculates NVS's fair value at $173 (base case), with a bear case of $109 and bull case of $227. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 51/100.

NVS trades at a forward P/E ratio of 16.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 20.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are optimistic on NVS, with a "Hold" consensus rating and $170 price target (15.6% upside). 6 of 25 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

NVS analyst price targets range from $170 to $170, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $170 consensus represents the middle ground. Our model's $109-$227 range provides an independent fundamental perspective.